Yahoo! Finance Finance Home - Yahoo! - Help
ThomsonFN

Registrations | Pricings | Withdrawals | Performers | IPOs

Brainstorm Cell TherapeuticsProposed Symbol - Nasdaq: BCLI

Address:
605 Third Avenue 34Th Floor
  New York, New York 10158
Financial Links
· Recent News


IPO Information as of 21-Nov-14
Offering Information
Expected Date-
Proposed Exchange/Ticker Nasdaq: BCLI
Security Type Units
Lead Underwriter Roth Capital Partners Inc Maxim Group LLC
Days In Registration 186
Date Filed -
Form FiledS-1
Fundamentals
(Year Ending December 2013)
Industry Manufacturing
Business Description BrainStorm Cell Therapeutics Inc, based in New York, New York, is a biotechnology company focuses on developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinsons Disease (PD).
Revenue -
Net Income -$4.3M
Shares Outstanding (post-offering) 176.24M
Contact -
Number of Employees -
Original Filing Information

US
Shares Filed -
Secondary Shares Filed-
  · As a Percent -
Primary Shares Filed -
  · As a Percent -
Overallotment Shares Filed -
File Amount $15.0M
File Price Range - - -
File Mid Price -


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
IPO information Copyright © 2014 Thomson Financial Securities Data (TFSD)
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Hoover's, Inc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.